Zimmer Biomet
Personalised joint replacement technology.
- Healthcare
- medical devices
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (3 %) | 2 % | 7 % | 4 % | 6 % | 5 % | 4 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 29 % | 29 % | 32 % | 32 % | 33 % | 33 % | 32 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 6 % | 3 % | 14 % | 12 % | 11 % | 12 % | 14 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 6 % | 6 % | 6 % | 6 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Zimmer Biomet is a leading company in the musculoskeletal healthcare industry, specializing in innovative solutions for joint replacement, surgical trauma, and sports medicine. With over 90 years of experience, Zimmer Biomet serves a diverse range of clients including hospitals, surgical centers, and orthopedic specialists. The company operates globally, providing advanced technologies such as robotically assisted surgeries and smart implants. Zimmer Biomet's business model focuses on the development, manufacturing, and marketing of medical devices and surgical instruments. Revenue is generated through the sale of these products and related services, including medical education and training for healthcare professionals. The company is committed to advancing healthcare through continuous innovation and strategic partnerships.
Keywords: musculoskeletal, healthcare, joint replacement, surgical trauma, sports medicine, orthopedic, robotically assisted, smart implants, medical devices, innovation.
Tech stack
Investments by Zimmer Biomet
Edit
